Company: PFSA
Filing Date: 2025-02-12
Form Type: S-4/A
Source: 0001213900-25-012354
Chunk: 47

Company: Profusa, Inc.
Filing Date: 2025-02-12
Form: S-4/A
Chunk 47
---
 stockholders who do not elect to have their shares of NorthView Common Stock redeemed for a pro rata share of the trust account need not submit their common stock or warrant certificates, and such shares of stock and warrants will remain outstanding. Q:Why is NorthView proposing the Business Combination? A:NorthView was organized to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses or entities. On December 22, 2021, NorthView completed its initial public offering of units, with each unit consisting of one share of NorthView Common Stock, one NorthView Right, and one -halfof one NorthView Warrant. Each NorthView Right entitles the holder thereof to receive one -tenthof one share of NorthView Common Stock, and each whole NorthView Warrant entitles the holder thereof to purchase one share of NorthView Common Stock at a price of $11.50, raising total gross proceeds of $189,750,000, reflecting the exercise in full of the underwriters’ over -allotmentoption. Since NorthView’s IPO, NorthView’s activity has been limited to the evaluation of business combination candidates. Profusa, Inc. is a digital health technology company based in Berkeley, CA, that has developed a real time, consumer -friendlyplatform which measures an individual’s biochemistry, is easy to use, cost -effective, and provides the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large population of potential users. Based on its investigations of Profusa and the industry in which it operates, including the financial and other information provided by Profusa in the course of their negotiations in connection with the Merger Agreement, NorthView believes that the Business Combination with Profusa is advisable and in the best interests of NorthView and its stockholders. See “ Proposal 1 — The Business Combination — The NorthView Board’s Reasons for the Approval of the Business Combination.” Q:Did the NorthView board obtain a third -party valuation or fairness opinion in determining whether or not to proceed with the Business Combination? A:Yes. Marshall & Stevens Transaction Advisory Services LLC (“Marshall & Stevens”) provided the NorthView Board a fairness opinion which concluded that, as of the date of its opinion, and based on and subject to the assumptions, qualifications and other matters set forth therein, the Aggregate Merger Consideration to be issued by NorthView in the Business Combination is fair, from a financial point of